Trial Profile
Clinical Trials Insight: 700058002
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 29 Jul 2010
Price :
$35
*
At a glance
- Drugs Arginine butyrate (Primary)
- Indications Haematological malignancies
- Focus Therapeutic Use
- Sponsors HemaQuest Pharmaceuticals
- 29 Jul 2010 New trial record